Treated	B:C0087111
Prevalence	O
of	O
Attention	O
-	I:C1263846
Deficit	I:C1263846
/	I:C1263846
Hyperactivity	I:C1263846
Disorder	I:C1263846
Increased	O
from	O
2009	O
to	O
2015	O
Among	O
School	O
-	O
Aged	O
Children	O
and	O
Adolescents	O
in	O
the	O
United	O
States	I:C0041703
.	O

Treated	O
Prevalence	O
of	O
Attention	B:C1263846
-	I:C1263846
Deficit	I:C1263846
/	I:C1263846
Hyperactivity	I:C1263846
Disorder	I:C1263846
Increased	O
from	O
2009	O
to	O
2015	O
Among	O
School	O
-	O
Aged	O
Children	O
and	O
Adolescents	O
in	O
the	O
United	O
States	I:C0041703
.	O

Treated	O
Prevalence	O
of	O
Attention	O
-	I:C1263846
Deficit	I:C1263846
/	I:C1263846
Hyperactivity	I:C1263846
Disorder	I:C1263846
Increased	O
from	O
2009	O
to	O
2015	O
Among	O
School	O
-	O
Aged	O
Children	O
and	O
Adolescents	O
in	O
the	O
United	B:C0041703
States	I:C0041703
.	O

The	O
purpose	O
of	O
this	O
brief	O
is	O
to	O
describe	O
changes	O
in	O
the	O
treated	B:C0087111
prevalence	O
of	O
medically	O
managed	O
attention	O
-	I:C1263846
deficit	I:C1263846
/	I:C1263846
hyperactivity	I:C1263846
disorder	I:C1263846
(	O
attention	O
-	I:C1263846
deficit	I:C1263846
/	I:C1263846
hyperactivity	I:C1263846
disorder	I:C1263846
)	O
among	O
insured	O
school	O
-	O
aged	O
children	O
and	O
adolescents	O
in	O
the	O
United	O
States	I:C0041703
from	O
2009	O
to	O
2015	O
.	O

The	O
purpose	O
of	O
this	O
brief	O
is	O
to	O
describe	O
changes	O
in	O
the	O
treated	O
prevalence	O
of	O
medically	O
managed	O
attention	B:C1263846
-	I:C1263846
deficit	I:C1263846
/	I:C1263846
hyperactivity	I:C1263846
disorder	I:C1263846
(	O
attention	O
-	I:C1263846
deficit	I:C1263846
/	I:C1263846
hyperactivity	I:C1263846
disorder	I:C1263846
)	O
among	O
insured	O
school	O
-	O
aged	O
children	O
and	O
adolescents	O
in	O
the	O
United	O
States	I:C0041703
from	O
2009	O
to	O
2015	O
.	O

The	O
purpose	O
of	O
this	O
brief	O
is	O
to	O
describe	O
changes	O
in	O
the	O
treated	O
prevalence	O
of	O
medically	O
managed	O
attention	O
-	I:C1263846
deficit	I:C1263846
/	I:C1263846
hyperactivity	I:C1263846
disorder	I:C1263846
(	O
attention	B:C1263846
-	I:C1263846
deficit	I:C1263846
/	I:C1263846
hyperactivity	I:C1263846
disorder	I:C1263846
)	O
among	O
insured	O
school	O
-	O
aged	O
children	O
and	O
adolescents	O
in	O
the	O
United	O
States	I:C0041703
from	O
2009	O
to	O
2015	O
.	O

The	O
purpose	O
of	O
this	O
brief	O
is	O
to	O
describe	O
changes	O
in	O
the	O
treated	O
prevalence	O
of	O
medically	O
managed	O
attention	O
-	I:C1263846
deficit	I:C1263846
/	I:C1263846
hyperactivity	I:C1263846
disorder	I:C1263846
(	O
attention	O
-	I:C1263846
deficit	I:C1263846
/	I:C1263846
hyperactivity	I:C1263846
disorder	I:C1263846
)	O
among	O
insured	O
school	O
-	O
aged	O
children	O
and	O
adolescents	O
in	O
the	O
United	B:C0041703
States	I:C0041703
from	O
2009	O
to	O
2015	O
.	O

We	O
examine	B:C0332128
the	O
differences	O
between	O
those	O
with	O
employer	O
-	O
sponsored	O
insurance	O
(	O
ESI	O
)	O
and	O
with	O
Medicaid	O
insurance	I:C0021682
.	O

We	O
examine	O
the	O
differences	O
between	O
those	O
with	O
employer	O
-	O
sponsored	O
insurance	O
(	O
ESI	O
)	O
and	O
with	O
Medicaid	B:C0021682
insurance	I:C0021682
.	O

We	O
utilized	O
two	O
large	O
longitudinal	B:C0205127
administrative	O
datasets	I:C0150098
containing	O
medical	O
and	O
drug	O
claims	O
data	O
on	O
individuals	O
with	O
ESI	O
and	O
Medicaid	O
insurance	I:C0021682
from	O
Truven	O
Health	I:C0242356
MarketScan	I:C0242356
(®	I:C0242356
)	I:C0242356
Administrative	I:C0242356
Claims	I:C0242356
Databases	I:C0242356
.	O

We	O
utilized	O
two	O
large	O
longitudinal	O
administrative	B:C0150098
datasets	I:C0150098
containing	O
medical	O
and	O
drug	O
claims	O
data	O
on	O
individuals	O
with	O
ESI	O
and	O
Medicaid	O
insurance	I:C0021682
from	O
Truven	O
Health	I:C0242356
MarketScan	I:C0242356
(®	I:C0242356
)	I:C0242356
Administrative	I:C0242356
Claims	I:C0242356
Databases	I:C0242356
.	O

We	O
utilized	O
two	O
large	O
longitudinal	O
administrative	O
datasets	I:C0150098
containing	O
medical	O
and	O
drug	B:C0013227
claims	O
data	O
on	O
individuals	O
with	O
ESI	O
and	O
Medicaid	O
insurance	I:C0021682
from	O
Truven	O
Health	I:C0242356
MarketScan	I:C0242356
(®	I:C0242356
)	I:C0242356
Administrative	I:C0242356
Claims	I:C0242356
Databases	I:C0242356
.	O

We	O
utilized	O
two	O
large	O
longitudinal	O
administrative	O
datasets	I:C0150098
containing	O
medical	O
and	O
drug	O
claims	O
data	O
on	O
individuals	B:C0237401
with	O
ESI	O
and	O
Medicaid	O
insurance	I:C0021682
from	O
Truven	O
Health	I:C0242356
MarketScan	I:C0242356
(®	I:C0242356
)	I:C0242356
Administrative	I:C0242356
Claims	I:C0242356
Databases	I:C0242356
.	O

We	O
utilized	O
two	O
large	O
longitudinal	O
administrative	O
datasets	I:C0150098
containing	O
medical	O
and	O
drug	O
claims	O
data	O
on	O
individuals	O
with	O
ESI	O
and	O
Medicaid	B:C0021682
insurance	I:C0021682
from	O
Truven	O
Health	I:C0242356
MarketScan	I:C0242356
(®	I:C0242356
)	I:C0242356
Administrative	I:C0242356
Claims	I:C0242356
Databases	I:C0242356
.	O

We	O
utilized	O
two	O
large	O
longitudinal	O
administrative	O
datasets	I:C0150098
containing	O
medical	O
and	O
drug	O
claims	O
data	O
on	O
individuals	O
with	O
ESI	O
and	O
Medicaid	O
insurance	I:C0021682
from	O
Truven	B:C0242356
Health	I:C0242356
MarketScan	I:C0242356
(®	I:C0242356
)	I:C0242356
Administrative	I:C0242356
Claims	I:C0242356
Databases	I:C0242356
.	O

Treated	B:C0087111
prevalence	O
was	O
measured	O
as	O
the	O
percentage	O
of	O
school	O
-	O
aged	O
children	O
and	O
adolescents	O
enrolled	O
in	O
a	O
calendar	O
year	O
who	O
met	O
the	O
criteria	O
for	O
medically	O
managed	O
attention	O
-	I:C1263846
deficit	I:C1263846
/	I:C1263846
hyperactivity	I:C1263846
disorder	I:C1263846
in	O
the	O
same	O
calendar	O
year	O
.	O

Treated	O
prevalence	O
was	O
measured	O
as	O
the	O
percentage	O
of	O
school	O
-	O
aged	O
children	O
and	O
adolescents	O
enrolled	O
in	O
a	O
calendar	O
year	O
who	O
met	O
the	O
criteria	O
for	O
medically	O
managed	O
attention	B:C1263846
-	I:C1263846
deficit	I:C1263846
/	I:C1263846
hyperactivity	I:C1263846
disorder	I:C1263846
in	O
the	O
same	O
calendar	O
year	O
.	O

Subjects	B:C0080105
were	O
eligible	O
for	O
inclusion	O
if	O
they	O
were	O
aged	O
6	O
-	O
17	O
years	O
and	O
were	O
continuously	O
enrolled	O
during	O
a	O
calendar	O
year	O
.	O

The	O
annual	O
prevalence	O
of	O
treated	B:C0087111
attention	O
-	I:C1263846
deficit	I:C1263846
/	I:C1263846
hyperactivity	I:C1263846
disorder	I:C1263846
among	O
school	O
-	O
aged	O
children	O
and	O
adolescents	O
with	O
ESI	O
increased	O
from	O
4.5	O
%	O
in	O
2009	O
to	O
6.7	O
%	O
in	O
2015	O
.	O

The	O
annual	O
prevalence	O
of	O
treated	O
attention	B:C1263846
-	I:C1263846
deficit	I:C1263846
/	I:C1263846
hyperactivity	I:C1263846
disorder	I:C1263846
among	O
school	O
-	O
aged	O
children	O
and	O
adolescents	O
with	O
ESI	O
increased	O
from	O
4.5	O
%	O
in	O
2009	O
to	O
6.7	O
%	O
in	O
2015	O
.	O

Among	O
those	O
with	O
Medicaid	B:C0021682
it	O
increased	O
from	O
11.3	O
%	O
in	O
2009	O
to	O
13.3	O
%	O
in	O
2012	O
,	O
and	O
fell	O
after	O
2012	O
,	O
remaining	O
steady	O
from	O
2013	O
through	O
2015	O
.	O

Treated	B:C0087111
prevalence	O
of	O
attention	O
-	I:C1263846
deficit	I:C1263846
/	I:C1263846
hyperactivity	I:C1263846
disorder	I:C1263846
increased	O
continuously	O
over	O
time	O
among	O
school	O
-	O
aged	O
children	O
and	O
adolescents	O
with	O
ESI	O
,	O
but	O
declined	O
slightly	O
after	O
2012	O
among	O
those	O
in	O
the	O
Medicaid	O
sample	I:C0021682
.	O

Treated	O
prevalence	O
of	O
attention	B:C1263846
-	I:C1263846
deficit	I:C1263846
/	I:C1263846
hyperactivity	I:C1263846
disorder	I:C1263846
increased	O
continuously	O
over	O
time	O
among	O
school	O
-	O
aged	O
children	O
and	O
adolescents	O
with	O
ESI	O
,	O
but	O
declined	O
slightly	O
after	O
2012	O
among	O
those	O
in	O
the	O
Medicaid	O
sample	I:C0021682
.	O

Treated	O
prevalence	O
of	O
attention	O
-	I:C1263846
deficit	I:C1263846
/	I:C1263846
hyperactivity	I:C1263846
disorder	I:C1263846
increased	O
continuously	O
over	O
time	O
among	O
school	O
-	O
aged	O
children	O
and	O
adolescents	O
with	O
ESI	O
,	O
but	O
declined	O
slightly	O
after	O
2012	O
among	O
those	O
in	O
the	O
Medicaid	B:C0021682
sample	I:C0021682
.	O

